Reoviridae

Full Title

dsRNA viruses > Details > Reoviridae

Child Classifications

Navigate with arrow keys, Enter to open

• C12N 2720/12021 Viruses as such, e.g. new isolates, mutants or their genomic sequences
• C12N 2720/12022 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
• C12N 2720/12023 Virus like particles [VLP]
• C12N 2720/12031 Uses of virus other than therapeutic or vaccine, e.g. disinfectant
• C12N 2720/12032 Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
• C12N 2720/12033 Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
• C12N 2720/12034 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
• C12N 2720/12041 Use of virus, viral particle or viral elements as a vector
• C12N 2720/12051 Methods of production or purification of viral material
• C12N 2720/12061 Methods of inactivation or attenuation
• C12N 2720/12071 Demonstrated in vivo effect
• C12N 2720/12088 for redistribution
• C12N 2720/12111 Orbivirus, e.g. bluetongue virus
• C12N 2720/12211 Orthoreovirus, e.g. mammalian orthoreovirus
• C12N 2720/12311 Rotavirus, e.g. rotavirus A